Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|January 23, 2023
Ruxolitinib does not completely abrogate the functional capabilities of TLR4/9 ligand-activated NK cellsCarmen Mestre-Durán, Carla Martín-Cortázar, Blanca García-Solís, et al.
Transfusion|March 16, 2018
How do we manufacture clinical-grade interleukin-15-stimulated natural killer cell products for cancer treatment?Lucía Fernández, Alejandra Leivas, Jaime Valentín, et al.
Frontiers in Immunology|August 21, 2019
Anti-CXCR4 Antibody Combined With Activated and Expanded Natural Killer Cells for Sarcoma ImmunotherapyMaria Vela, David Bueno, Pablo González-Navarro, et al.
Neuromuscular Disorders : NMD|November 19, 2011
Screening for mutations in Spanish families with myotonia. Functional analysis of novel mutations in CLCN1 geneMaría J Mazón, Francisco Barros, Pilar De la Peña, et al.
International Journal of Surgical Pathology|May 6, 2024
Periosteal Ewing Sarcoma with Distant Metastases: Report of Two Patients and Review of the LiteratureEva M Pena-Burgos, María C Díez-Corral, Eduardo J Ortiz-Cruz, et al.
Iscience|February 23, 2026
Nanoencapsulated senotherapeutic compounds targeting connexin-43 for enhanced wound healingMarina Rodríguez-Candela Mateos, Jenifer García-Fernández, Sofia M Saraiva, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 23, 2018
Unexpected High Incidence of Human Herpesvirus-6 Encephalitis after Naive T Cell-Depleted Graft of Haploidentical Stem Cell Transplantation in Pediatric PatientsLuisa Sisinni, Mercedes Gasior, Raquel de Paz, et al.
Journal of Personalized Medicine|June 24, 2022
Advanced Molecular Characterisation in Relapsed and Refractory Paediatric Acute Leukaemia, the Key for Personalised MedicineVíctor Galán-Gómez, Nerea Matamala, Beatriz Ruz-Caracuel, et al.
Cancers|February 5, 2021
Optimizing the Procedure to Manufacture Clinical-Grade NK Cells for Adoptive ImmunotherapyAdrián Fernández, Alfonso Navarro-Zapata, Adela Escudero, et al.
Pediatric Hematology and Oncology|March 4, 2021
Ruxolitinib for steroid-refractory graft versus host disease in pediatric HSCT: high response rate and manageable toxicityYasmina Mozo, David Bueno, Luisa Sisinni, et al.
Pageof 3